Free Trial

Microbot Medical (MBOT) Competitors

Microbot Medical logo
$3.37 -0.17 (-4.80%)
Closing price 04:00 PM Eastern
Extended Trading
$3.38 +0.00 (+0.15%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MBOT vs. BVS, AVNS, ZIMV, KIDS, TMCI, SMLR, CBLL, DCTH, SNWV, and BFLY

Should you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), CeriBell (CBLL), Delcath Systems (DCTH), Sanuwave Health (SNWV), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry.

Microbot Medical vs. Its Competitors

Microbot Medical (NASDAQ:MBOT) and Bioventus (NASDAQ:BVS) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

In the previous week, Microbot Medical had 2 more articles in the media than Bioventus. MarketBeat recorded 2 mentions for Microbot Medical and 0 mentions for Bioventus. Bioventus' average media sentiment score of 0.00 beat Microbot Medical's score of -0.12 indicating that Bioventus is being referred to more favorably in the news media.

Company Overall Sentiment
Microbot Medical Neutral
Bioventus Neutral

Microbot Medical has a net margin of 0.00% compared to Bioventus' net margin of -0.03%. Bioventus' return on equity of 23.04% beat Microbot Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Microbot MedicalN/A -76.27% -67.54%
Bioventus -0.03%23.04%6.04%

Microbot Medical has higher earnings, but lower revenue than Bioventus.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbot MedicalN/AN/A-$11.44M-$0.58-5.81
Bioventus$573.28M1.02-$33.54MN/AN/A

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 62.9% of Bioventus shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Comparatively, 33.0% of Bioventus shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Microbot Medical presently has a consensus target price of $9.00, suggesting a potential upside of 167.06%. Given Microbot Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Microbot Medical is more favorable than Bioventus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microbot Medical
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Bioventus
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Microbot Medical has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. Comparatively, Bioventus has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500.

Summary

Microbot Medical and Bioventus tied by winning 7 of the 14 factors compared between the two stocks.

Get Microbot Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBOT vs. The Competition

MetricMicrobot MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$161.23M$6.90B$5.76B$9.85B
Dividend YieldN/A1.22%6.71%4.51%
P/E Ratio-5.8118.4859.1122.53
Price / SalesN/A70.07547.00119.09
Price / CashN/A21.6037.0558.92
Price / Book19.824.9010.916.06
Net Income-$11.44M$178.27M$3.29B$266.28M
7 Day Performance-15.75%-0.61%0.01%-0.76%
1 Month Performance27.17%1.88%7.06%3.83%
1 Year Performance305.34%9.93%50.09%24.39%

Microbot Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBOT
Microbot Medical
2.0293 of 5 stars
$3.37
-4.8%
$9.00
+167.1%
+306.9%$161.23MN/A-5.8120
BVS
Bioventus
N/A$7.44
-2.6%
N/AN/A$631.67M$573.28M15.281,200
AVNS
AVANOS MEDICAL
2.6639 of 5 stars
$11.58
-1.2%
N/A-48.7%$543.37M$687.80M-1.152,227Positive News
ZIMV
ZimVie
0.7302 of 5 stars
$18.96
+0.1%
$17.75
-6.4%
+9.6%$534.41M$449.75M-27.091,770News Coverage
Positive News
KIDS
OrthoPediatrics
4.4197 of 5 stars
$20.29
+0.4%
$34.14
+68.3%
-31.5%$506.49M$204.73M-11.34200Positive News
TMCI
Treace Medical Concepts
2.5732 of 5 stars
$7.47
-3.0%
$9.83
+31.6%
+26.7%$486.43M$209.36M-9.46250Positive News
Analyst Forecast
SMLR
Semler Scientific
3.4532 of 5 stars
$30.02
-4.5%
$81.75
+172.3%
+17.8%$465.31M$56.29M3.74120News Coverage
CBLL
CeriBell
2.579 of 5 stars
$11.44
-5.1%
$32.14
+181.0%
N/A$442.17M$65.44M-3.83N/A
DCTH
Delcath Systems
3.1666 of 5 stars
$10.89
-2.1%
$24.50
+125.0%
+3.2%$388.99M$37.21M217.8060Positive News
SNWV
Sanuwave Health
N/A$42.66
-5.2%
$55.00
+28.9%
N/A$385.56M$32.63M0.0040News Coverage
Analyst Forecast
BFLY
Butterfly Network
3.1929 of 5 stars
$1.56
+2.3%
$3.00
+92.9%
+26.5%$382.65M$82.06M-5.55460Positive News

Related Companies and Tools


This page (NASDAQ:MBOT) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners